Report - CLINICAL REVIEW - Food and Drug Administration · Clinical Review Joanna K. Zawadzki, M.D. NDA 20-986 (047) SE5 NovoLog (insulin aspart) Novo Nordisk, Inc.

Please pass captcha verification before submit form